Search En menu ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

    Signature(s)

    Amount
    € 26,000,000
    Countries
    Sector(s)
    Cyprus : € 26,000,000
    Health : € 5,200,000
    Services : € 20,800,000
    Signature date(s)
    1/06/2017 : € 5,200,000
    1/06/2017 : € 20,800,000

    Summary sheet

    Release date
    15 April 2016
    Status
    Reference
    Signed | 01/06/2017
    20160037
    Project name
    Promoter - financial intermediary
    CYPRUS INSTITUTE FOR NEUROLOGY AND GENETICS R&D
    THE CYPRUS FOUNDATION FOR MUSCULAR DYSTROPHY RESEARCH
    Proposed EIB finance (Approximate amount)
    Total cost (Approximate amount)
    EUR 21 million
    EUR 31 million
    Location
    Sector(s)
    Description
    Objectives

    The project includes construction of an extension and purchase of equipment as well as the intangible cost of research activities at the Cyprus Institute of Neurology and Genetics.

    The purpose of the project is to enhance the services, research and academic activities performed at the Cyprus Institute of Neurology and Genetics. The EIB will mainly support investments in new research and development (R&D) infrastructure as well as research programmes. The project is fully consistent with the Bank's Knowledge Economy objectives and the targets agreed in the context of the EU Horizon 2020.

    Environmental aspects
    Procurement

    Hospitals and medical research institutes are not specifically mentioned in the Environmental Impact Assessment (EIA) Directive 2011/92/EU as amended, though the project is covered by Annex II of the directive in relation to urban development. The Bank's services will verify during appraisal whether an EIA is required by the competent authority.

    The Bank will require the promoter to ensure that contracts for the implementation of the project have been/shall be tendered in accordance with the relevant applicable EU procurement legislation (Directives 2004/18/EC or 2014/24/EU where applicable, and/or 2004/17/EC, or 2014/25/EU where applicable, as well as Directives 89/665/EEC and 92/13/EEC) as interpreted by the Court of Justice of the EU, with publication of tender notices in the Official Journal of the EU, as and where required.

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Documents

    Environmental and Social Data Sheet (ESDS) - CYPRUS INSTITUTE FOR NEUROLOGY AND GENETICS R&D
    Publication Date
    24 Dec 2016
    Document language
    Main Topic
    Lending
    Document Number
    67162431
    Document Focus
    Environmental Information
    Project Number
    20160037
    Sector(s)
    Regions
    Countries
    Publicly available
    Download now

    General enquiries and comments

    The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
    Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
    Alternatively, the EIB can be contacted through its external offices.
    Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

    Media enquiries

    Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

    Complaints mechanism

    Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

    Zero tolerance against fraud and corruption

    The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.

    Related publications